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Abstract Protein glycosylation, which is a key post-transla-
tional event, is catalysed by the glycosyltransferase family of
enzymes. There is an increasing body of evidence to suggest that
these enzymes may themselves be glycosylated, possibly as an
autocatalytic event. Using a novel in vitro system, we have
investigated the role of enzyme glycosylation in sialyltransferase
catalytic activity. The enzyme activity is glycosylation depen-
dent, with the penultimate galactose residue on complex N-linked
oligosaccharides playing a pivotal role. These results serve to
underline the complexity of the glycosylation process. ß 2002
Federation of European Biochemical Societies. Published by
Elsevier Science B.V. All rights reserved.
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1. Introduction
Glycosylation is a key post-translational event, primarily
associated with membrane-bound and secreted proteins [1].
Proteins are glycosylated in a speci¢c manner that is deter-
mined by their route through the endoplasmic reticulum and
Golgi. Furthermore, with few exceptions, this is an irreversible
process and is viewed as a mechanism by which glycoprotein
function and processing can be controlled.
The negatively charged sialic acid residues, which exert a
particular in£uence on the 3-dimensional structure of their
protein backbone, are located at the non-reducing terminal
end of N-linked complex and hybrid oligosaccharides, primar-
ily in K2,3 and K2,6 linkages to a penultimate galactose resi-
due. The transfer of these residues is catalysed by the ST3N
and ST6N members of the sialyltransferase (STN) group of
enzymes [2] whose activity is modi¢ed by a number of factors
including oncogene expression [3], second messenger systems
[4], steroid hormones [5] and heavy metals [6]. Indeed, it has
been proposed that the STN enzymes themselves may be gly-
cosylated, possibly by an autocatalytic mechanism, thus pro-
viding another mechanism for the control of enzyme activity.
Sialic acid can also be attached to a complex N-linked ol-
igosaccharide chain in an K2,8 linkage. The transfer of the
terminal sialic acid residue and the subsequent elongation of
the chain, which is expressed almost exclusively on the neural
cell adhesion molecule, NCAM, is catalysed by the PST and
STX polysialyltransferase enzymes [2]. These enzymes have
also been demonstrated to be capable of autopolysialylation
both in vitro and in vivo [7,8]. Initial studies suggested that
while polysialylation of the enzyme enhances the polysialic
acid (PSA) content of NCAM, it is not an absolute prereq-
uisite [9]. More detailed studies have demonstrated that PST/
STX enzymes lacking sialic acid and galactose are, in fact,
inactive in the catalysis of the polysialylation of either the
enzyme or the NCAM protein [10]. Other glycosyltransferase
enzymes can also be glycosylated and this has been proposed
to play a role in enzyme stability, their subcellular distribution
within the cell [11^15] and the modi¢cation of their catalytic
activity [16,17].
Determining the role of individual sugar residues of oligo-
saccharide chains in protein function and processing can be
particularly di⁄cult as there are relatively few su⁄ciently se-
lective tools with which to modify the activities of individual
glycosyltransferase or glycosidase enzymes. While the genera-
tion of stably transfected cell lines is one approach that can be
taken [18], the over-expression of certain glycosyltransferase
enzymes may actually disrupt the cellular glycosylation ma-
chinery [19]. However, a number of mutant Chinese hamster
ovary (CHO) cell lines have previously been generated, each
of which exhibits a speci¢c glycosylation defect [20]. These
provide an excellent tool with which to study the role of in-
dividual sugar residues in protein processing and in this study,
we have demonstrated that both terminal sialic acid and ga-
lactose residues on N-linked oligosaccharides play a pivotal
role in determining STN catalytic activity using these cell
lines.
2. Materials and methods
2.1. Cell culture
Control (Pro 5) and mutant (Lec 1, 2 and 8) CHO cell lines [20]
were obtained from the American Type Culture Collection. The cells
were cultured in Dulbecco’s modi¢ed Eagle’s medium containing 10%
foetal calf serum, penicillin (2 U/ml) and streptomycin (0.25 mg/ml)
and maintained at 37‡C in a humidi¢ed atmosphere containing 5%
CO2. They were routinely trypsinised upon reaching con£uency and
seeded at a density of 2.2U106 cells per 75 cm2 tissue culture £ask.
The cells were harvested by scraping into a phosphate-bu¡ered saline
solution and pelletted by centrifugation at 15 000 rpm for 3 min at
4‡C. The cell pellets were stored at 320‡C until use.
2.2. STN assay
Total cellular STN activity was determined using cytidine-5-mono-
phosphate-4,5,6,7,8,9-14C-N-acetylneuraminic acid (CMP-14C-Neu5-
Ac, Radiochemical Centre, Amersham; speci¢c activity 293 mCi/
mmol) as the sialic acid donor and asialofetuin (Sigma) as an exoge-
nous acceptor [21].
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2.3. Lectin blot analysis
Although they have been previously published, the glycosylation
potential of the individual cell lines was con¢rmed for the present
study by lectin blot analysis using digoxigenin-labelled lectins (Boehr-
inger Mannheim) as previously described [18]. The terminal sialic acid
(in an K2,6 linkage) was identi¢ed using the Sambucus Nigra (SNA)
lectin; the penultimate Gal-GlcNAc disaccharide group was identi¢ed
by the Phaseolus Vulgaris lectin; the GlcNAc-Man disaccharide iden-
ti¢ed by the Datura Stramonium lectin and the (Man)2-Man branched
trisaccharide by the Galanthus Rivalis lectin. Samples were treated
with 5 U N-glycosidase F for 2 h at 37‡C (Boehringer Mannheim).
2.4. Polyacrylamide gel electrophoresis
The protein content of the samples was determined colourometri-
cally [22]. The individual polypeptide components of the samples were
separated by discontinuous SDS polyacrylamide gel electrophoresis
and transferred to PVDF membranes (Millipore) by electroblotting
as previously described [18]. All lanes were loaded equally with 50
Wg protein unless otherwise stated. The ST6N protein was visualised
by Western blot analysis using a polyclonal antibody (kind gift of
Prof. Eric Berger, University of Zurich) [18].
3. Results
The cell lines have the title ‘Lec’ to indicate that they are
resistant to the binding of certain plant lectins that label spe-
ci¢c oligosaccharide units. Initially, their glycosylation status
was con¢rmed using appropriate lectins. All four cell lines
exhibited a lectin-binding spectrum that was consistent with
their mutations (Fig. 1A). The Pro 5 cell lysates (control) were
labelled by all four lectins used in the study con¢rming that
they express a complex N-linked sugar chain. However, the
staining intensity of the GNA lectin blot was somewhat weak-
er than in the other cell lines with this staining probably being
masked by the expression of the negatively charged terminal
sialic acid residue. The Lec 2 cell line has a dysfunctional
CMP-sialic acid transporter, resulting in an inability of the
activated sugar to enter the Golgi cisternae with the resultant
abolition of SNA lectin labelling of terminal sialic acid resi-
dues. The Lec 8 cells are lacking the UDP-galactose trans-
porter, thus preventing the transfer of the penultimate galac-
tose residue (and by implication a terminal sialic acid residue)
onto the complex oligosaccharide chain. This resulted in the
lack of binding of both the SNA and PHA-L lectins. The Lec
8 cell line has a dysfunctional GlcNAc T1 transferase enzyme
resulting in N-linked sugars blocked at the Man5-GlcNAc2-
Asn stage and abolishing its ability to bind the DSA lectin.
The cellular glycoproteins are, however, labelled by the DSA
lectin that recognises oligosaccharide chains containing the
trimannosyl core sugar. Lectin blots label a large number of
proteins rather than individual bands, hence, the non-resolved
Fig. 1. A: The labelling of total cell glycoproteins with the SNA, PHA-L, GNA and DSA lectins. The migration of the molecular weight
markers is indicated. Individual protein bands that express high levels of speci¢c oligosaccharide epitopes are indicated. B: Schematic diagram
of a complex N-linked oligosaccharide and the approximate lectin binding sites.
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nature of the blots. However, some individual bands, corre-
sponding to proteins expressing large levels of a speci¢c oli-
gosaccharide epitope, can be identi¢ed. These are labelled
accordingly.
Total cellular STN activity was similar in the Pro 5 and Lec
2 cell lines, indicating that the removal of the terminal sialic
acid residue had minimal e¡ect on enzyme activity (Fig. 2).
However, there was a 60% decrease in the catalytic activity in
both the Lec 8 and Lec 1 cell lines when compared with the
Pro 5 cells, suggesting that the presence of a penultimate ga-
lactose residue is a critical component of the oligosaccharide
chain that is required for optimal enzyme activity. The sub-
sequent removal of the GlcNAc residue had no obvious in£u-
ence on enzyme activity.
In the control cells, the ST6N enzyme appeared as a dou-
blet of 44 and 48 kDa. A similar pattern was observed in the
Lec 2 cells. However, in the Lec 8 and Lec 1 cells, only the
single lower molecular weight band could be detected (Fig.
3A). Treatment of the ST6N doublet in the Pro 5 cells with
N-glycosidase F resulted in the abolition of the higher band,
suggesting that it represents a glycosylated form of the en-
zyme (Fig. 3B).
4. Discussion
The concept of kinase phosphorylation (including auto-
phosphorylation) has been well characterised and it plays a
key role in modifying enzyme activity [23]. The concept of
glycosylation of glycosyltransferase enzymes is, however, still
relatively poorly understood [13]. Early studies reported that
STN exists as a glycoprotein [24,25] although the signi¢cance
of this concept remained unclear. More recent studies have
shown that although glycosylation is not required for catalytic
activity of the ST6Gal I enzyme in vitro, the deglycosylated
form of the enzyme has no catalytic activity in vivo, possibly
because of altered enzyme protein oligomerisation and aggre-
gation within the Golgi [12]. The PST enzymes (PST/STX)
have also been demonstrated to be autosialylated and contain
the PSA oligosaccharide chain [7,8]. There appears, however,
to be some disagreement as to whether, for example, PST/
STX autopolysialylation is an absolute requirement for en-
zyme activity or if it purely modi¢es activity [9]. The most
recent evidence suggests that the former is indeed the case
[10].
One primary problem in the ¢eld of glycobiology is the lack
of sensitive tools with which to investigate the e¡ects of al-
tered glycosylation on protein structure, function and process-
ing. There are inherent problems with over-expressing (or
knocking out) glycosyltransferase enzymes in cell lines by
transfection as this has been reported to upset the subcellular
distribution or functional roles of other Golgi enzymes [19].
While the generation of proteins with mutated glycosylation
sites (usually Asn residues) or treatment with agents such as
tunicamycin both act to completely block the glycosylation
process, they are not su⁄ciently sensitive to provide any in-
formation on the role of individual sugar residues. Deoxy-
mannojirimycin, which acts to block mannosidase II, is some-
what more sensitive as it allows for the di¡erentiation between
high mannose and complex oligosaccharides [26,27]. The
CHO mutant cell lines generated by Stanley in 1975 [28]
have therefore proven to be an ideal tool with which to in-
vestigate the functional role of protein glycosylation.
In these cells, the ST6N enzyme exists as a doublet of 44
and 48 kDa. While the presence of sialic acid on complex and
hybrid N-linked oligosaccharide chains does not appear to be
a prerequisite for STN activity, the lack of both sialic acid and
galactose residues results in a signi¢cant decrease in catalytic
activity. This is in broad agreement with previous studies that
demonstrate that ST6N sialylation is not required optimal
enzyme activity [29].
An ST6N dimmer has been previously reported with the
two bands di¡ering according to their glycosylation states
[29,30]. Altered cellular sialylation potential in cells trans-
fected with ST6N also resulted in a glycosylation-associated
modi¢cation of the protein molecular size. The higher molec-
ular weight 48 kDa form in the Pro 5 cells corresponds to the
glycosylated form while the lower 44 kDa species is likely to
be deglycosylated. This was con¢rmed by the removal of
N-linked oligosaccharides by treatment with N-glycosidase F
which resulted in a concomitant shift to the lower molecular
weight band. The di¡erential expression of these two forms of
the enzyme mirrors well its catalytic activity, with the cells
expressing the 48 kDa form exhibiting the highest enzymatic
activity.
It was of interest to note, however, that the decrease in
catalytic activity associated with sequential sugar removal
was not a step-wise process and only two glycoforms could
be detected. Indeed, the higher molecular weight band re-
mained the primary form of the enzyme even in the absence
of a charged sialic acid residue in the Lec 2 cells. This suggests
that the enzyme may only have a very limited sialic acid con-
tent and therefore, its expression in a cell line incapable of
Fig. 2. Total STN activity in the individual cell lines (n = 3).
*P6 0.05 (ANOVA followed by Tukey^Kramer multiple compari-
sons test).
Fig. 3. A: Expression of the ST6N enzyme protein in the individual
cell lines as determined by Western blot analysis. The approximate
molecular weight of the protein bands is indicated. B: Treatment of
the cell homogenate with glycosidase F for 18 h at 37‡C prior to
analysis.
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sialylation has little e¡ect on the enzyme glycosylation state or
activity. In the Lec 8 cells, which lack the subsequent galac-
tose residue, the signi¢cant decrease in activity, with the loss
of the higher 48 kDa band suggests that the penultimate ga-
lactose is a key residue. This was con¢rmed in the Lec 1 cells
whereby the absence of a subsequent N-acetylgalactosamine
residue had no e¡ect. Indeed, the removal of all sugars by
endoglycosidase F did not generate a protein band that was
signi¢cantly di¡erent to that observed in the Lec 8 cells.
Protein glycosylation plays a speci¢c role in the catalytic
activity of other glycosyltransferase enzymes although it is
likely that this varies signi¢cantly between individual enzymes.
These include K1,3-fucosyltransferase [13,16], M1,4-N-acetylga-
lactosaminyltransferase and GD3 synthase [14,17]. While we
have demonstrated that glycosylation plays a role in, but is
not an absolute requirement for, the catalytic activity of the
ST6N enzyme, its overall signi¢cance remains to be deter-
mined. Future detailed studies on enzyme glycosylation in
vivo should assist in increasing our knowledge on this topic.
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